Number of predicted peptides that could bind to HLA-A, HLA-B, and HLA-DR according to SYFPEITHI
. | No. of peptides . | . | . | ||
|---|---|---|---|---|---|
| Patient no. . | HLA-A . | HLA-B . | HLA-DR . | ||
| 1 | 16 (A1) | 11 (B*1510) | 47 (DRB1*0401 = DR4Dw4) | ||
| 45 (A*0201) | |||||
| 2 | 24 (A1) | 31 (B*08) | 41 (DRB1*0301 = DR17) | ||
| 55 (DRB1*0401 = DR4Dw4) | |||||
| 3 | 48 (A*0201) | 23 (B*0702) | 29 (DRB1*1101) | ||
| 13 (B*1510) | |||||
| 4 | 34 (A*0201) | 13 (B*0702) | 33 (DRB1*0301 = DR17) | ||
| 5 | 58 (A3) | 23 (B*0702) | 57 (DRB1*0401 = DR4) | ||
| Total | 225 | 114 | 262 | ||
. | No. of peptides . | . | . | ||
|---|---|---|---|---|---|
| Patient no. . | HLA-A . | HLA-B . | HLA-DR . | ||
| 1 | 16 (A1) | 11 (B*1510) | 47 (DRB1*0401 = DR4Dw4) | ||
| 45 (A*0201) | |||||
| 2 | 24 (A1) | 31 (B*08) | 41 (DRB1*0301 = DR17) | ||
| 55 (DRB1*0401 = DR4Dw4) | |||||
| 3 | 48 (A*0201) | 23 (B*0702) | 29 (DRB1*1101) | ||
| 13 (B*1510) | |||||
| 4 | 34 (A*0201) | 13 (B*0702) | 33 (DRB1*0301 = DR17) | ||
| 5 | 58 (A3) | 23 (B*0702) | 57 (DRB1*0401 = DR4) | ||
| Total | 225 | 114 | 262 | ||
HLA types are indicated in parentheses.
Predicted peptides are defined as a binding capacity score of at least 9 (“Patients, materials, and methods”).